Loading...
26-003418
Response Deadline
May 22, 2026, 2:00 PM(EDT)10 days
Eligibility
Contract Type
Combined Synopsis/Solicitation
COMBINED SYNOPSIS / SOLICITATION WORKFORM
(1) Action Code: Combined Synopsis/Solicitation
(2) Date: May 12
(3) Year: 2026
(4) Contracting Office Zip Code: 20817
(5) Classification Code: 6640
(6) Contracting Office Address:
6701 Rockledge Drive
Bethesda, MD 20817
(7) Subject/Title: CFX Opus 96 Real-Time PCR System
(8) Solicitation Number: 26-003418
(9) Closing Response Date: May 22, 2026 @ 10am. Eastern Daylight Time (EDT)
(10) Contact Point(s): Towanda Daniels, Purchasing Agent
(11) Contract Award Type: Firm Fixed Price
(12) Brand Name or Equal Acquisition (FAR 52.211-6): Yes
(13) Description:
(i) “This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Subpart 12.6 as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested, and a written solicitation will not be issued.”
(ii) The solicitation number and a statement that the solicitation is issued as a request for quote (RFQ).
(iii) The solicitation document, the incorporated provisions, and clauses are those in effect through Federal Acquisition Circular, FAC Number: 2026-01
Effective Date: 03/13/2026
(iv) This solicitation is being released unrestricted. The NAICS code is 334516, and the small business size standard is 1000 employees. This acquisition is being conducted in accordance with the procedures of FAR Part 12 and FAR Part 13.
(v) The equipment consists of a real-time PCR system capable of supporting multiplex nucleic acid detection and analysis. The system must provide accurate thermal control, reliable fluorescence detection, and compatibility with existing laboratory software and experimental workflows.
The following product features/characteristics are required for this requirement:
System can capture up to five fluorophores in a single reaction well using “All
Channels” scan mode, or, for faster scanning time, one fluorophore when using the SYBRR/FAM or FRET Scan Modes.
Fixed optical path, directly over each well, eliminates the need to normalize for positional bias or passive dye calibration.
System does not have lid or drawer that extends beyond the footprint of the system nor requires additional operating clearance.
Dimensions (W x D x H) is 13x22x14 inches; can easily fit under a standard shelf
Real-time data traces can be viewed during a run from the thermal cycler base or on CFX Maestro (if a computer is connected to the instrument).
CFX Maestro software is compatible with all real time PCR results from the older model CFX system the lab has been using; it shall ensure project continuity.
Multiple plates can be combined into one experiment with the Gene Study Feature on the free CFX Maestro software.
Software performs t-tests and 1-way ANOVA calculations.
The requested system, from Bio-Rad shall provide multiplexing capability, thermal uniformity, and compatibility with existing laboratory workflows and data analysis software to support current and future research requirements.
The provisions at FAR Clause 52.212-1, Instructions to Offerors – Commercial Items, applies to this acquisition. The following addendum related to the Instructions to Offerors is included:
Addendum to FAR Clause 52.212-1, Instructions to Offerors – Commercial Items. Please refer to this addendum for additional attachments, including the Statement of Work and other relevant information.
Evaluations will be conducted in accordance with the provision at FAR Clause 52.212-2. Offerors will be evaluated as follows:
EVALUATION-COMMERCIAL ITEMS (OCT 2014)
(a) The Government will award a contract resulting from this solicitation to the responsible offeror whose offer conforming to the solicitation will be most advantageous to the Government, price and other factors considered. The following factors shall be used to evaluate offers:
• Technical
• Past Performance
• Cost
All evaluation factors other than cost or price, when combined are significantly more important than cost or price.
Written notice of award or acceptance of an offer, mailed or otherwise furnished to the successful offeror within the time for acceptance specified in the offer, shall result in a binding contract without further action by either party. Before the offer’s specified expiration time, the Government may accept an offer (or part of an offer), whether or not there are negotiations after its receipt, unless a written notice of withdrawal is received before award.
Please refer to the addendum for additional evaluation information.
Each Offeror must include a completed copy of the provision at FAR clause 52.212-3, Offeror Representations and Certifications – Commercial Items, with its offer.
Please note, each Offeror shall complete only paragraph (b) of this provision if the Offeror has completed the annual representations and certification electronically via the System for Award Management (SAM) website located at
https://www.sam.gov/portal.
FAR Clause 52.212-4, Contract Terms and Conditions – Commercial Items, applies to this acquisition. The terms and conditions outlined in the following addendum also apply:
Addendum to FAR Clause 52.212-4, Contract Terms and Conditions – Commercial Items. Please refer to this addendum for additional terms and conditions related to the requirement.
FAR Clause 52.212-5, Contract Terms and Conditions Required to Implement Statutes or Executive Orders – Commercial Items, applies to this acquisition. The full text version of FAR 52.212-5 included in the addenda as Attachment 5 indicate which FAR clauses and provisions are applicable to this acquisition.
Contact Information:
Towanda Daniels
Email: danielt@mail.nih.gov
(14) Place of Contract Performance: Bethesda, MD
(15) Set-aside Status: N/A
DEPARTMENT OF HEALTH AND HUMAN SERVICES
NATIONAL INSTITUTES OF HEALTH
NATIONAL INSTITUTES OF HEALTH OLAO
NATIONAL INSTITUTES OF HEALTH OLAO
6011 EXECUTIVE BLVD., SUITE 503L
BETHESDA, MD, 20892
NAICS
Biological Product (except Diagnostic) Manufacturing
PSC
LABORATORY EQUIPMENT AND SUPPLIES
Set-Aside
No Set aside used